Scholarlink

<p>The earliest clinical sign of pulmonary vascular disease in neonates is persistent pulmonary hypertension of the newborn (PPHN), traditionally classified as World Symposium on Pulmonary Hypertension (WSPH) Group 1. Typical PPHN is defined by the delayed transition from intra- to extra- uterine life with failure of pulmonary artery pressures to fall after delivery. This results in sustained elevation of pulmonary vascular resistance and contributes to hypoxemic respiratory failure (HRF). However, early HRF can also arise from atypical PPHN phenotypes that may persist beyond the expected resolution of typical PPHN and are often classified within WSPH Groups 2, 3 and 5. In addition, a history of PPHN can be associated with the childhood and adulthood PH. In this perspective, we highlight the diverse etiologies contributing to the PPHN phenotype, with a focus on Group 3 disease, and propose a physiology-based framework to classify PPHN and delineate disease trajectories.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Phenotyping persistent pulmonary hypertension of the newborn: recognition of its persistence across world symposium on pulmonary hypertension classifications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月4日

查看全文
  • Stephanie M. Tsoi,
  • Philip T. Levy,
  • Steven H. Abman,
  • Nidhy P. Varghese

摘要

The earliest clinical sign of pulmonary vascular disease in neonates is persistent pulmonary hypertension of the newborn (PPHN), traditionally classified as World Symposium on Pulmonary Hypertension (WSPH) Group 1. Typical PPHN is defined by the delayed transition from intra- to extra- uterine life with failure of pulmonary artery pressures to fall after delivery. This results in sustained elevation of pulmonary vascular resistance and contributes to hypoxemic respiratory failure (HRF). However, early HRF can also arise from atypical PPHN phenotypes that may persist beyond the expected resolution of typical PPHN and are often classified within WSPH Groups 2, 3 and 5. In addition, a history of PPHN can be associated with the childhood and adulthood PH. In this perspective, we highlight the diverse etiologies contributing to the PPHN phenotype, with a focus on Group 3 disease, and propose a physiology-based framework to classify PPHN and delineate disease trajectories.